ºÃÎĵµ - רҵÎÄÊéд×÷·¶ÎÄ·þÎñ×ÊÁÏ·ÖÏíÍøÕ¾

À±Ä¾¼ò½é 

ÓÉ ÌìÏ ·ÖÏí ʱ¼ä£º ¼ÓÈëÊÕ²Ø ÎÒҪͶ¸å µãÔÞ

ºÜ¶àÈËÈÏΪÓйÇÖÊÊèËÉÖ¢µÄÈ˳ԸÆƬ¾Í¿ÉÒÔ½â¾öÎÊÌ⣬µ«¸ù¾Ý¹ãÖÝÈÕ±¨2004Äê3ÔÂ23ÈÕÔÚµÚ°Ë°æÿÈÕ±£½¡À¸Ä¿±¨µÀ£ºÖлªÒ½Ñ§»á¹Ç¿Æ·Ö»áÖ÷ÈÎίԱÇñ¹óÐËÈÏΪ£¬µ¥³Ô¸ÆƬ¶ÔÀÏÄê¹ÇÖÊÊèËÉÎÞЧ£¬¸Æ»ù±¾É϶¼´Ó´ó±ãÖÐÅųöµÈÓÚû³Ô¡£ÓÖ¸ù¾ÝͬÈÕ¹ãÖÝÈÕ±¨ÁíÒ»±¨µÀ£º¡°°¢ÆųÔÈâ¶àÒ×¹ÇÕÛ¡±£¬ÃÀ¹úÁÙ´²ÓªÑøÔÓÖ¾·¢±í±¨¸æ¡£Ñо¿Ô±Èû¶ûÂõÒ®Ö¸³ö£¬ÒûʳÖи÷ÖÖµ°°×ÖÊ¿ÉÒÔ¶Ô¹ÇÍ·µÄг´úлÆðµ½²»Í¬µÄ×÷Óá£Ëý˵£¬¶¯ÎïʳƷÖÐÌṩµÄÖ÷ÒªÊÇÇ°ÌåËᣬ¶øÖ²ÎïʳƷÖе°°×º¬Óлù´¡Ç°ÇýÎï¡£ÒûʳÖÐÇ°ÌåËáºÍ»ù´¡Ç°Çý¶¯ÎïÖ®¼äʧȥƽºâ¾Í¿ÉÄÜÒýÆðËáÐÔÎïÖÊ»ýÀÛ£¬¶Ô¹ÇÍ·Æð²»Á¼×÷Óá£Èû¶ûÂõҮ˵£º¡°±¨¸æ½áÂÛÊÇ£¬ÒûʳÖÐÔö¼ÓÖ²Îïµ°°×µÄÉãÈ룬ͬʱ¼õÉÙ¶¯Îïµ°°×£¬¿ÉÒÔ¼õÉٹɹÇ×éÖ¯µÄɥʧºÍ÷ŹǹÇÕÛµÄΣÏÕ¡£¡±

¸ù¾ÝÉÏÊöÁ½Î»È¨ÍþÈËÊ¿¼°×¨¼ÒµÄ±¨µÀ£¬µ¥¿¿Ò©Îï»ò¶¯Îïµ°°×ÖÎÁÆÀà´Ë¼²²¡¶¼²»ÊÇÀíÏë°ì·¨¡£

´Ó»¯Ñé½á¹ûµÃ³ö½áÂÛ¿´£¬À±Ä¾Ê÷º¬ÓÐÌرð¸ßµÄÖ²Îï¸ÆÖÊ£¬Ã¿100gÀ±Ä¾Ê÷Ò¶¸ÉÔï·Ûº¬ÓÐ1320mgµÄ¸Æ£¬Ö»Òª75g¾Í¿ÉÒÔÌṩ1000mgÄÐÐÔÿÈÕËùÐèµÄ¸Æ60g¾Í¿ÉÒÔÌṩ800mgÅ®ÐÔÿÈÕËùÐèµÄ¸Æ£¬¶ÔÀÏÈ˶øÑÔ£¬ËäȻʳÁ¿²»´ó£¬Ã¿Ìì³Ô¼¸³×À±Ä¾Ê÷Ò¶·Û¾ø¶Ô¿ÉÒÔ½ÓÊÜ£¬Ö»ÒªÃ¿Ìì¼á³ÖÒûÓ㬾ͿÉÒÔ±ÜÃâ¹ÇÖÊÊèËÉÖ¢²úÉú£¬ºÎ¿öÀ±Ä¾Ê÷²úÆ·¶Ô±£³ÖÉíÌ彡¿µ»¹Óкܶౣ½¡×÷ÓÃ. À±Ä¾Ê÷»¹º¬ÓиßÁ¿µÄ°×°±Ëᣬǿµ÷¼õ·Êʱ¼õµôµÄÊÇÖ¬·¾¶ø²»ÊǼ¡Èâµ°°×ÖÊ£¬¶ø¸ß¸ÆÓÖÊǼõ·ÊÒûʳµÄÖØÒªÌõ¼þ£¬¿É¼ûÀ±Ä¾Ê÷ҶʵÔÚÊǼõ·Ê²ÍµÄÀíÏë²ÄÁÏ.

´ËÍâ¸ß¸ÆÒûʳÕß»¼½á³¦°©±ÈµÍ¸ÆÒûʳÕßµÍ35£¥£¬ÉúÓýÆڵĸ¾Å®ÉãÈ¡¸ß¸ÆÒûʳ¿É½µµÍ»¼Èé°©µÄ»úÂÊ30£¥£¬ÄÜ´ïµ½·À°©Ä¿µÄ¸ÆÉãÈ¡Á¿ÊÇÿÈÕ1000¡ª1500mg¡£

ÃÀ¹úÄ¿Ç°½¨Òé¸ÆÉãÈ¡Á¿ÊÇ50ËêÒÔϵijÉÄêÈËÿÈÕ1000mg£¬50ËêÒÔÉÏÕßΪ1200mg¡£ ¢ó£®¸ßѪѹ

À±Ä¾Ê÷Ò¶º¬¼ØÁ¿¸ß£¬ÓÐÖúÓÚÞ׿¹¹úÈËÏ°¹ßµÄ¸ßÄÆÒûʳ£º¸ßÄÆÒûʳ»áµ¼Ö¸ßѪѹ£¬¸ß¼ØÒûʳÔòÄÜÔ¤·À¸ßѪѹ¡£

Ó¡¶ÈÈËÏàÐÅÀ±Ä¾Ê÷Ò¶Ö­¶ÔѪѹÓа²¶¨×÷Ó㬿ÉÓÃÒÔÖÎÁƽ¹ÂÇÖ¢¡£Chaudhury²©Ê¿Ò²Ö¸³öÀ±Ä¾Ê÷ÊǺÜÓпÉÄÜ¿ª·¢³ÉΪÖθßѪѹҩÎïµÄ´«Í³Ò©Îï(Chaudhury¡ªRR£¨1995£©£¬Principles OfPharmacology£º

Basicconceptsand clinical applications£¬Eds£ºPLMunson£¬RAMueller&GR Breese£®Chapman&HaIIInternarional(NewYork)£®Pp 1530-1533)¡£ ÔÚº£µØ(Haiti)£¬À±Ä¾Ê÷Ò¶Ò²±»ÓÃÓÚÖÎÁƸßѪѹ֢¡£

À±Ä¾Ê÷Ò¶³ýÁ˸߼ØÖ®Í⣬Ҳȷʵº¬ÓоßÓнµÑªÑ¹¹¦Ð§µÄÌØÊâ³É·Ý£º1992ÄêFaiziµÈÈË´ÓÀ±Ä¾Ê÷Ò¶ÖзÖÀëµÃµ½ÎåÖÖ½µÑªÑ¹³É·Ö£ºniazininA£¬niazininB£¬niazimicin£¬niazimicinA¼°niazimicinB¡£ÕâÊÇÊ×´ÎÔÚÖ²ÎïÐÔ²ÄÁÏÖз¢Ïֿ󻯰·»ùËữºÏÎï(Faizi£¬S.£¬

B.S.Siddiqui,etal.(1992).Isolation and_ structureelucidation Ofnovel hypotensive agents£¬niazi-ninA,niazinin B£¬niazimicin and niazimininAplua B from Morinfla oleifera£º

Thefirstnaturallyoccurring thiocarbamates£®Jouernal Ofthe ChemicalSo_

cietyPerkinTransationsI(23)£º

3237-3241{a}H£®E£®J£®Res£®Inst£®Chem£®UnMKaeachi£¬Karachi£¬Karachi¡ª75270£¬Pakistan)£®ºóÐøµÄÑо¿·¢ÏÖÀ±Ä¾Ê÷µÄË®ÝÍÒºÔÚµÍŨ¶ÈÏÂ

ÄÜÌá¸ßÐÄÌøËÙÂÊ£¬¶øÔÚ¸ßŨ¶ÈÏ»á¼õµÍÐÄÌøËÙÂʲ¢½µµÍѪѹ¡£²Î¿¼×ÊÁÏ£º 1£®Faizi£¬S?£¬B£®S£®Siddiqui£¬elaI£®(1994)£®tionandstructureelu_ cidation Ofnewnitrileand mustard O¡§glycosidesfrom Moringa effectOn blood pressure£®JournaI OfNatural ProductsLloydia 57(9)£º1256-1261£®{a}H£®E£®J£®Res£®Inst£®Chem?£¬Univ£®Karachi£¬Karachi 75270£¬Pakistan£®

2£®FaiziS.£¬B£®S¡£Siddiqui£¬

elal.(1995)£®Fullyacetylatedcarbamateand

hypotensivethiocarbamate glycosidesfrom Moringa Oleifera£®Phytoch¡ª

emistry Oxford 38(4)£º957-963£® a

H£®E.J.Res£®Inst£®em.Univ,Karachi£¬Karachi 752270£¬Pakiatan£® 3£®Faizi£¬S?£¬B£®S£®Siddiqui£¬e{aI£®(1998)£® econstituentsfrom Thepods Of Moringaoleifera£®PlantaMedica64(3)£º225¡ª228£® a H£®E£®J.Res.Inst£®Chem.£¬Univ£®Karachi£¬Karachi 75270£¬Pakistan) ´ËÍ⣬À±Ä¾Ê÷Ò¶Ò²Óн¡Î¸µÄ¹¦Ð§£¬À±Ä¾Ê÷Ò¶µÄ¼×´¼È¡Òº¶ÔÀÏÊó(100mg£¯KgºÍ100mg£¯Kg)ÄÜÏÔ×ŵطÀÖ¹ÓÉ°¢Ë¾Æ¥ÁÖ£¬ÑªÇåËØ(serotonin)ºÍindomethacinËùÒýÆðµÄθ²¿É˺¦£¬Ò²ÄÜÏÔÖøµØÔö¼ÓÓÉ´×ËáËùÒýÆðµÄθ²¿É˺¦Ö®ÖÎÓúËÙÂÊ¡£

¶¯ÎïÊÔÑé·¢ÏÖÀ±Ä¾Ê÷¾¥Æ¤µÄË®ÝÍÒºÒ²ÄܽµµÍ¹·µÄѪѹ¡£ ¢ô£®ÏûÑ×£¬Ô¤·À¸ÐȾ

ÉãÈ¡³ä·ÖµÄ¸ÆºÍάÉúËØA(»òºúÂܲ·ËØ)ÄÜÌá¸ß¶Ô¼²²¡µÄÃâÒßÁ¦£¬ÌرðÊÇÏñ¸Ðð֮ÀàµÄ¸ÐȾÐÔ¼²²¡¡£ÔÚÈûÄÚ¼Ó¶û·¢ÏÖÄÌ·ÛÖÐÌí¼ÓÀ±Ä¾Ê÷Ò¶·Ûʱ£¬

Ó¤¡¢Ó׶ù¹Ò²¡ºÅµÄ´ÎÊýÃ÷ÏÔ¼õÉÙ¡£

ÈÕ³£»î¶¯ÖÐÃâ²»ÁË·¢ÉúһЩСÐ͵ÄÍâÉË£¬ÓÐʱ»¹»á½øÒ»²½»¯Å§¸ÐȾ£¬ÕâʱÀ±Ä¾Ê÷¸ùËùº¬µÄÀ±Ä¾Ê÷ËؾͿÉÒÔÅÉÉÏÓó¡¡£Ö»Òª0£®5¡«3£¯µg£®£¯ccŨ¶È¾ÍÄÜÒÖÖƺܶà¸ñÀ¼ÊÏÑôÐÔ¾úºÍÒõÐÔ¾úµÄÉú³¤£¬°üÀ¨½ð»ÆŧÇò¾ú¡¢¿Ý²Ý¸Ë¾ú¡¢´ó³¦¸Ë¾ú¡¢ÂÌŧ¸Ë¾ú¡¢É˺®¸Ë¾ú¡¢³¦Ñ׸˾ú¡¢¸±É˺®¸Ë¾ú¡¢Á¡¼²¸Ë¾ú¡¢²Ý·ÖÖ¦¸Ë¾ú¡¢·Î½áºËÇò¾ú¡¢¸ü¸ßŨ¶Èʱ(7¡ª10£¯µg£®£¯cc)»¹¿ÉÒÔÒÖÖÆù¾úµÄÉú³¤¡£°ÑÀ±Ä¾Ê÷¸ùÖƳÉÍâÓÃÒ©¸à£¬¿É×÷ΪÍâÉËÓÃÒ©¡£ À±Ä¾Ê÷Ò¶µÄ¼×´¼£¬ÒÒÃÑ»òÈýÂȼ×ÍéÝÍÈ¡Îï¶ÔƤѢ¾ú(0ermatophytes)ÓÐÁ¼ºÃµÄ¿ØÖÆЧ¹û¡£Æ¤Ñ¢¾úÊÇÏã¸Û½ÅµÄ²¡Ô­¾ú£¬À±Ä¾Ê÷Ò¶ÝÍÈ¡Îï´ï10mg£¯mLŨ¶È¾ÍÄÜÒÖÖÆ£¬³¬¹ý20mg£¯mLÔòÄÜɱÃðƤѢ¾úTrichophyton mentagrophyteSºÍT.Simmii(Ind£®J.Pharmac£®9(4)£º269¡ª272£¬1977¡£ÖøÕß½¨Òé,ÓøÉÔïÀ±Ä¾Ê÷Ò¶·Û¶¶ºÏ·²Ê¿ÁÖ»òÇ×Ë®Èí¸à¿É×÷ΪÏã¸Û½ÅµÄÍâÓÃÒ©¡£

°Í»ù˹̹µÄÑо¿Õß´ÓÀ±Ä¾Ê÷Ò¶ÖзÖÀ룬´¿»¯³öÈýÖÖË®ÈÜÐÔµÄС·Ö×ÓÁ¿µ°°×ÖÊ£¬¶Ô¶àÖÖϸ¾úÓÐÒÖÖÆЧ¹û£¬°üÀ¨´ó³¦¸Ë¾ú¡¢¿ËÀ×ÊϲúÂȸ˾ú¡¢¿ËÀ×ÊÏ·ÎÑ׸˾ú¡¢½ð»ÆÆÏÌÑÇò¾ú¡¢¿Ý²Ý¸Ë¾ú¡¢ºÚù¾ú¡¢»Æ¾úÒÔ¼°Çàù¾ú¡£ ÃÀ¹úרÀûµÚ6£¬383£¬495ºÅ½éÉÜÓøÉÔïÀ±Ä¾Ê÷Ò¶ºÍ³¤±ú¾Õ(Tr{dax procumbens)Ò¶µÄÀäÒº¡¢Â«ÜöÖ­¡¢ÉñÂÞÀÕ(0clmum sanctum)£¬¾«ÓÍ£¬ÈéÏã(Gum olibanum)µÈÖƳÉÒ©¸à£¬¿ÉÓÃÒÔÖÎÁƻᷢÁƲ¢ÓÐ×ÆÈȸеÄʪÕҲ¿ÉÒÔÓÃÀ´È¥³ýÒѾ­½ÇÖÊ»¯µÄËÀƤ£¬È缦Ñ۵ȡ£¿É¼ûÀ±Ä¾Ê÷µÄÏûÑ×Ч¹ûÒѾ­´Ó´«Í³µÄÃñË×ÁÆ·¨½ø²½µ½ÌáÈ¡³É·ÖÖƳÉÒ©Æ·µÄ¾«Ï¸»¯¹¤¾³½ç¡£ V. ¿¹²¡¶¾¡¢Ö×Áö

Ó¡¶È´«Í³Ò½Ñ§ÉÏÓÃÀ±Ä¾Ê÷¸ùÀ´ÖÎÁÆË®ÅÝ£¬À£ÑñºÍÖ×Áö¡£ÒÔÀ±Ä¾Ê÷Ò¶ÖÎ

ÁÆÀ£Ññ£¬Ö×ÁöºÍÑо¿±¨¸æÔÚ½ü¿´À´Ò²±¬Ôö£»AktarºÍAhmadÈÏΪ»¨Ñ¿ÄÜÖÎÀ£Ññ£¬MurakamiµÈÈ˺ÍGuevaraµÄÑо¿ÍŶÓÈÏΪÀ±Ä¾Ê÷Ò¶Óп¹°©Ð§¹û¡£ ÔÚÓ¡¶ÈÔòÓÃÖÖ×ÓÔ¼10£¥Óпª·¢³É¿¹°©Ò©ÎïDZÁ¦µÄ³É·Ý£¬Ä¿Ç°ÔÚÓ¢¹úµÄʳƷÑо¿ËùµÃ(lnstituteofFoodResearch£¬Norwich£¬UK)½øÐÐÊÔÑéÖеÄÓÐ4-(a¡¯-L¡ªRhamnopyrano-syloxy)-benxyl glucosinolatehºÍ3-Hydrosy£¬4?(a¡¯-L-Rhamnopyranosyloxy)?benzylglucosinolateµÈµÈ¡£

À±Ä¾¼ò½é

À±Ä¾(ѧÃûMoringa)Ô­²úÓÚÓ¡¶ÈºÍ·ÇÖÞ,ÓÉÓÚËüÓÅÔ½µÄÓªÑø¼ÛÖµ,ÏÖÔڹ㷺ÖÖÖ²ÓÚÓ¡¶È¡¢·ÇÖÞ¡¢ÄÏÃÀÖÞ¡¢Öб±ÃÀÖÞ¶«ÄÏÑǹú¼Ò¡¢°Ä´óÀûÑÇ£¬½üÄ꿪ʼÒýÖÖµ½ÖйúÄÏ·½¸÷Ê¡¡£À±Ä¾Ê÷ÐÔ£ºÎ¶ÐÁ¡¢Î¢Î¡¢ÎÞ¶¾£¬ËüµÄ³É·ÖÓªÑø·á¸»£¬º¬ÓÐάÉúËØA£¬B£¬C£¬µ°°×ÖÊ£¬¸Æ£¬¼Ø£¬ÌúµÈ¿óÎïÖÊ¡£¸ù¾ÝÖйúÅ©Òµ²¿Êß²ËÆ·Öʼල¼ìÑé²âÊÔÖÐÐIJⶨ֤Ã÷£¬Ã¿100gµÄÀ±Ä¾Ò¶Æ¬Öк¬Óе°°×ÖÊ27.1¿Ë£¬Ô¼ÎªÅ£Ä̵Ä2±¶£»º¬Î¬ÉúËØC200ºÁ¿Ë£¬Ô¼ÎªÏʳȵÄ7±¶£»º¬Î¬ÉúËØA16.3ºÁ¿Ë£¬Ô¼ÎªºúÂܲ·µÄ4±¶£»º¬Ìú28.2ºÁ¿Ë£¬Ô¼Îª²¨²ËµÄ3±¶£»º¬¸Æ2003ºÁ¿Ë£¬Ô¼ÎªÅ£Ä̵Ä4±¶£»º¬¼Ø1324ºÁ¿Ë£¬Ô¼ÎªÏ㽶µÄ3±¶¡£À±Ä¾µÄÓ¦Óãº1.ʳÓãºÀ±Ä¾µÄÄÛÒ¶¡¢ÖÖ×Ó¡¢¹û¼Ô¡¢¸ùµÈ¶¼ÊÇ¿ÉÒÔ×÷ΪÓÅÁ¼µÄʳƷ¡£À±Ä¾ÓªÑø·á¸»¶øÈ«Ã棬Äܲ¹³äÓªÑø¡¢Ìá¸ßÈËÌåÃâÒßÄÜÁ¦µÈ¡£2.Ò©ÓãºÔÚÀ±Ä¾µÄÔ­²úµØÓ¡¶ÈºÍ·ÇÖÞ£¬À±Ä¾ÊÇÒ»ÖÖ´«Í³µÄÒ©ÓÃÖ²Î¹ã·ºÓÃÓÚ¸÷ÖÖ¼²²¡µÄÖÎÁÆ¡£Ê¹ÓÃÀ±Ä¾Ò¶×Ó£¬ÖÎÁÆ·¢ÉÕ¡¢Ö§Æø¹ÜÑס¢ÑÛ¡¢¶úµÄ¸ÐȾ£¬»µÑªÖ¢ºÍճĤÑ×£»Ò¶Ö­ÓÃÓÚÎȶ¨ÑªÑ¹¡¢½µµÍѪÌÇ¡¢ÖÎÁƾ«Éñ½¹ÂÇ£»·óÀ±Ä¾Ò¶¸àÓÃÀ´ÖÎÁÆÀ£ÑñºÍƤ·ô¸ÐȾ£»»¨µÄ´«Í³ÓÃ;ÊÇ×̲¹¡¢ÀûÄòµÈ¡£¹û¼Ô¿É×÷Çý³æ¼Á£¬Ò²¿ÉÖÎÁƸÎÆ¢¼²²¡ºÍ¹Ø½ÚÑס£Ê÷¸ù¡¢Ê÷Ƥ¡¢Ê÷Ö¬ºÍÖÖ×Ó¶¼¿ÉÓÃÓÚijЩ¼²²¡µÄÖÎÁÆ¡£3.¾»Ë®£ºÀ±Ä¾ÖÖ×ÓÈÊÀﺬÓдóÁ¿µÄµÍ·Ö×ÓË®ÈÜÐÔµ°°×£¬ËüÄÜÓëË®ÖеÄÄàɳ¡¢Ï¸¾úµÈ½á

À±Ä¾¼ò½é 

ºÜ¶àÈËÈÏΪÓйÇÖÊÊèËÉÖ¢µÄÈ˳ԸÆƬ¾Í¿ÉÒÔ½â¾öÎÊÌ⣬µ«¸ù¾Ý¹ãÖÝÈÕ±¨2004Äê3ÔÂ23ÈÕÔÚµÚ°Ë°æÿÈÕ±£½¡À¸Ä¿±¨µÀ£ºÖлªÒ½Ñ§»á¹Ç¿Æ·Ö»áÖ÷ÈÎίԱÇñ¹óÐËÈÏΪ£¬µ¥³Ô¸ÆƬ¶ÔÀÏÄê¹ÇÖÊÊèËÉÎÞЧ£¬¸Æ»ù±¾É϶¼´Ó´ó±ãÖÐÅųöµÈÓÚû³Ô¡£ÓÖ¸ù¾ÝͬÈÕ¹ãÖÝÈÕ±¨ÁíÒ»±¨µÀ£º¡°°¢ÆųÔÈâ¶àÒ×¹ÇÕÛ¡±£¬ÃÀ¹úÁÙ´²ÓªÑøÔÓÖ¾·¢±í±¨¸æ¡£Ñо¿Ô±Èû¶ûÂõÒ®Ö¸³ö£¬ÒûʳÖи÷ÖÖµ°°×ÖÊ¿ÉÒÔ¶Ô¹ÇÍ·µÄг´úлÆðµ½²»Í¬µÄ×÷Óá£Ëý˵£¬¶¯ÎïʳƷÖÐÌṩµÄÖ÷ÒªÊÇÇ°ÌåËᣬ
ÍƼö¶È£º
µã»÷ÏÂÔØÎĵµÎĵµÎªdoc¸ñʽ
12fhb8lxn168ub00wpkv
ÁìÈ¡¸£Àû

΢ÐÅɨÂëÁìÈ¡¸£Àû

΢ÐÅɨÂë·ÖÏí